140 related articles for article (PubMed ID: 7792222)
1. Treatment of childhood dermatophyte infections with oral terbinafine.
Goulden V; Goodfield MJ
Pediatr Dermatol; 1995 Mar; 12(1):53-4. PubMed ID: 7792222
[TBL] [Abstract][Full Text] [Related]
2. Proximal subungual hyperkeratosis of the big toe due to Microsporum gypseum.
Romano C; Massai L
Acta Derm Venereol; 2001; 81(5):371-2. PubMed ID: 11800151
[No Abstract] [Full Text] [Related]
3. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
4. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails.
Roberts DT
Dermatology; 1997; 194 Suppl 1():37-9. PubMed ID: 9154400
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine for dermatophytes in skin and nail.
Drug Ther Bull; 1992 Jun; 30(12):47-8. PubMed ID: 1623815
[No Abstract] [Full Text] [Related]
6. The efficacy and safety of terbinafine in children.
Gupta AK; Adamiak A; Cooper EA
J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):627-40. PubMed ID: 14761128
[TBL] [Abstract][Full Text] [Related]
7. Overview of the use of terbinafine (Lamisil) in children.
Jones TC
Br J Dermatol; 1995 May; 132(5):683-9. PubMed ID: 7772471
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.
Hofbauer B; Leitner I; Ryder NS
Med Mycol; 2002 Apr; 40(2):179-83. PubMed ID: 12058731
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
10. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
11. Significance of non-dermatophyte moulds and yeasts in onychomycosis.
Ellis DH; Marley JE; Watson AB; Williams TG
Dermatology; 1997; 194 Suppl 1():40-2. PubMed ID: 9154401
[TBL] [Abstract][Full Text] [Related]
12. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
Balfour JA; Faulds D
Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222
[TBL] [Abstract][Full Text] [Related]
13. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
14. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
Davis R; Balfour JA
Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
[TBL] [Abstract][Full Text] [Related]
15. Tinea faciei due to Microsporum canis abscess formation.
Patel G; Mills C
Clin Exp Dermatol; 2000 Nov; 25(8):608-10. PubMed ID: 11167972
[TBL] [Abstract][Full Text] [Related]
16. [Systemic terbinafine treatment of dermatophytoses in children].
Wilmer A; Wollina U
Mycoses; 1998; 41 Suppl 2():54-7. PubMed ID: 10085688
[TBL] [Abstract][Full Text] [Related]
17. Skin and nail fungi-almost beaten.
Finlay AY
BMJ; 1999 Jul; 319(7202):71-2. PubMed ID: 10398610
[No Abstract] [Full Text] [Related]
18. Successful treatment of subcutaneous phaeohyphomycosis owing to Exophiala jeanselmei with oral terbinafine.
Rallis E; Frangoulis E
Int J Dermatol; 2006 Nov; 45(11):1369-70. PubMed ID: 17076729
[No Abstract] [Full Text] [Related]
19. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
20. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.
Villars VV; Jones TC
Br J Dermatol; 1992 Feb; 126 Suppl 39():61-9. PubMed ID: 1543676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
